HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 242 filers reported holding HORIZON PHARMA PLC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $511,000 | -84.0% | 19,350 | -88.1% | 0.02% | -81.9% |
Q3 2018 | $3,190,000 | +18.2% | 162,900 | 0.0% | 0.12% | +13.7% |
Q2 2018 | $2,698,000 | +16.6% | 162,900 | 0.0% | 0.10% | +13.3% |
Q1 2018 | $2,313,000 | -2.7% | 162,900 | 0.0% | 0.09% | -2.2% |
Q4 2017 | $2,378,000 | +15.1% | 162,900 | 0.0% | 0.09% | +24.3% |
Q3 2017 | $2,066,000 | +6.8% | 162,900 | 0.0% | 0.07% | +2.8% |
Q2 2017 | $1,934,000 | -19.7% | 162,900 | 0.0% | 0.07% | -22.6% |
Q1 2017 | $2,408,000 | -8.6% | 162,900 | 0.0% | 0.09% | -17.0% |
Q4 2016 | $2,636,000 | -80.6% | 162,900 | -78.3% | 0.11% | -78.6% |
Q3 2016 | $13,596,000 | +10.1% | 749,900 | 0.0% | 0.52% | +3.8% |
Q2 2016 | $12,351,000 | -0.6% | 749,900 | 0.0% | 0.50% | -4.5% |
Q1 2016 | $12,426,000 | -23.5% | 749,900 | 0.0% | 0.53% | -10.4% |
Q4 2015 | $16,250,000 | +151.6% | 749,900 | +130.2% | 0.59% | +153.9% |
Q3 2015 | $6,458,000 | – | 325,800 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 5,664,219 | $83,717,000 | 10.14% |
Consonance Capital Management LP | 6,218,903 | $91,915,000 | 9.63% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,944,988 | $161,767,000 | 6.24% |
Rhenman & Partners Asset Management AB | 1,751,322 | $25,885,000 | 4.10% |
SCOPIA CAPITAL MANAGEMENT LP | 9,686,262 | $143,163,000 | 2.64% |
ARMISTICE CAPITAL, LLC | 850,000 | $12,563,000 | 2.59% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 2,959,258 | $43,738,000 | 2.40% |
Proxima Capital Management, LLC | 246,311 | $3,640,000 | 2.22% |
Beach Point Capital Management LP | 522,898 | $7,728,000 | 2.18% |
GRAYBILL WEALTH MANAGEMENT, LTD. | 165,260 | $2,443,000 | 1.94% |